EARLY CLINICAL-STUDIES WITH CB3717 ((N-(4-(N-(2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID